De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling

Catherine A Del Vecchio1, Yuxiong Feng1, Ethan S Sokol2

  • 1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America.

Plos Biology
|September 10, 2014
PubMed

Insights

De-differentiated cancers develop multidrug resistance (MDR) through PERK-Nrf2 signaling, not oxidative stress. Targeting this pathway can re-sensitize resistant cancer cells to chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Recurrent malignant carcinomas often exhibit de-differentiation and multidrug resistance (MDR).
  • The mechanisms by which de-differentiated cancer cells acquire MDR, including upregulation of reactive oxygen species (ROS)-scavenging enzymes and drug efflux pumps, remain unclear.
  • Understanding the regulation of these genes during de-differentiation is crucial for overcoming therapeutic resistance.

Purpose of the Study:

  • To identify ROS-induced genes upregulated in de-differentiated cells independent of oxidative damage.
  • To elucidate the signaling pathway responsible for preactivating the Nrf2 transcription factor in de-differentiated cancer cells.
  • To investigate the therapeutic potential of targeting this pathway in drug-resistant cancers.

Main Methods:

  • Global transcriptional profiling to identify upregulated genes in de-differentiated cells.
  • Analysis of the Nrf2 transcription factor activation mechanism in differentiated versus de-differentiated cells.
  • Experimental validation in basal breast cancer cell lines and animal models.
  • Correlation analysis of PERK pathway signature with clinical data from patient tumor datasets.

Main Results:

  • Nrf2, a master regulator of oxidative stress response, is preactivated in de-differentiated cells via a noncanonical mechanism involving PERK-mediated phosphorylation, independent of oxidative damage.
  • This constitutive PERK-Nrf2 signaling confers MDR by reducing ROS levels and increasing drug efflux.
  • Inhibition of the PERK-Nrf2 pathway reversed MDR in therapy-resistant basal breast cancer models.
  • A PERK pathway signature in patient tumors strongly correlates with chemotherapy resistance, higher tumor grade, and poorer overall survival.

Conclusions:

  • De-differentiated cancer cells utilize a PERK-Nrf2 signaling axis to upregulate MDR genes, distinct from canonical oxidative stress responses.
  • Targeting the PERK-Nrf2 pathway presents a promising strategy to overcome chemotherapy resistance in de-differentiated and multidrug-resistant cancers.
  • This pathway serves as a potential biomarker for predicting treatment response and patient prognosis.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
2.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
6.8K